Nigeria study finds drug storage gaps in veterinary clinics
Bottom line
A cross-sectional study of 23 veterinary clinics in Nigeria’s Federal Capital Territory found widespread gaps in drug storage temperature compliance, with 60.9% of clinics lacking temperature monitoring devices and average storage temperatures running above recommended maximums. The study suggests that routine storage conditions in these clinics may put medicine quality, potency, and treatment effectiveness at risk, especially for heat-sensitive products. The findings land against a broader Nigerian regulatory backdrop that increasingly emphasizes documented temperature monitoring and calibrated equipment across pharmaceutical storage and distribution. (nafdac.gov.ng)
Why it matters: For veterinary professionals, this is a clinic operations and patient safety issue, not just a facilities problem. If ambient storage areas routinely exceed labeled limits, products may degrade before expiry, creating a hidden cause of treatment failure, inconsistent response, or wasted inventory. That matters in any practice, but especially in hot climates and settings with unreliable power, where refrigerators, cold-chain products, backup systems, and excursion records can make the difference between usable stock and compromised medicine. (link.springer.com)
What to watch: Watch for follow-up work on enforcement, staff training, and whether clinics adopt routine temperature logs, calibrated monitors, and backup cold-chain plans in response to the findings. (nafdac.gov.ng)
Key facts
- Study design
- Cross-sectional assessment
- Sample size
- 23 veterinary clinics
- Region
- Nigeria’s Federal Capital Territory
- Main finding
- 60.9% of clinics lacked temperature monitoring devices
- Storage condition
- Mean storage temperatures exceeded recommended maximums
- Risk
- Medicine quality and clinical effectiveness may be reduced
- Regulatory context
- NAFDAC guidance calls for documented temperature monitoring and calibrated equipment
- Broader legal context
- Veterinary drug storage is covered under the Pharmacy Council of Nigeria Act 2022
A new study of veterinary clinics in Nigeria’s Federal Capital Territory points to a basic but consequential compliance gap: many clinics aren’t adequately monitoring drug storage temperatures. In the cross-sectional assessment of 23 clinics, 60.9% lacked temperature monitoring devices, and mean storage temperatures exceeded recommended maximums, raising concerns that medicines may be exposed to conditions that reduce quality and clinical effectiveness before they ever reach patients. (nafdac.gov.ng)
The issue sits at the intersection of clinic management, pharmaceutical quality, and regulation. In Nigeria, oversight of drug storage extends to veterinary drugs as well as human medicines under the Pharmacy Council of Nigeria Act 2022, while NAFDAC’s current good storage and distribution guidance calls for documented temperature monitoring data and calibrated monitoring equipment. In other words, the study’s findings don’t just highlight a practice gap; they point to a gap against an increasingly explicit compliance framework. (lawcarenigeria.com)
That broader context matters because temperature excursions aren’t a theoretical risk. Research in veterinary medicine has shown that labeled storage limits commonly sit around 25 C to 30 C for many products, and prolonged exposure above those limits can threaten stability. The Nigeria study’s finding that average clinic storage temperatures exceeded recommended maximums suggests some products may be spending meaningful time outside labeled conditions, particularly if clinics also lack continuous or even routine monitoring. Without logs, practices may have no way to identify excursions, quarantine affected stock, or document that products remained usable. (link.springer.com)
The findings also line up with wider concerns about medicine storage in Nigeria. The Pharmacy Council of Nigeria warned in late 2025 about unsafe storage practices across the country and said enforcement actions had targeted pharmacies, medicine stores, and unregistered shops. While that warning focused on the broader drug market, not veterinary clinics specifically, it reinforces the same operational message: storage conditions can undermine potency long before a product reaches its expiry date. That’s especially relevant in settings where high ambient heat and power instability complicate routine cold-chain management. (leadership.ng)
There doesn’t appear to be substantial published expert commentary yet tied directly to this specific study, but the regulatory and industry response around pharmaceutical storage is consistent. NAFDAC’s guidance emphasizes reviewable temperature records and calibrated equipment, and cold-chain service providers in Nigeria increasingly market real-time monitoring as a core safeguard for temperature-sensitive products. That doesn’t replace independent oversight, but it does show where operational expectations are heading. (nafdac.gov.ng)
Why it matters: For veterinary professionals, this study is a reminder that medicine performance depends on storage discipline as much as prescribing. A clinic can choose the right product, dose, and protocol, then still see weaker-than-expected outcomes if stock has been exposed to heat or refrigeration failures. For practice leaders, the practical implications are straightforward: verify labeled storage ranges, install calibrated min-max or continuous monitors, maintain logs, map hot spots in storage areas, train staff on excursion response, and have contingency plans for outages. Those steps protect patients, reduce inventory loss, and strengthen defensibility if regulators or suppliers ask how products were handled. (nafdac.gov.ng)
The study may also have supply-chain implications beyond the clinic shelf. If products arrive from distributors already stressed by transport or warehousing conditions, in-clinic monitoring alone won’t solve the problem. That makes documentation across the full chain, from wholesaler to refrigerator to treatment room, more important in regions where heat exposure is hard to avoid. The same logic applies to vaccines, biologics, and other products with narrower temperature tolerances. (nafdac.gov.ng)
What to watch: The next signal to watch is whether these findings translate into local audits, updated clinic SOPs, or professional guidance from Nigerian veterinary and pharmacy stakeholders, especially around monitoring devices, excursion documentation, and backup power for temperature-sensitive stock. (lawcarenigeria.com)